Does Early Weight Loss Following Laparoscopic Sleeve Gastrectomy Affect Long-term Outcomes
NCT ID: NCT04235829
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
156 participants
OBSERVATIONAL
2012-04-01
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients
NCT02931292
Evaluation of Functional and Social Changes After Bariatric Surgery
NCT02962193
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
NCT01828528
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
NCT04325581
Factors Influencing the Positive Outcome of Bariatric Surgery for Morbidly Obese Patients
NCT01583790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using the contact details available in the medical records, a scripted telephone interview was performed. The current weight of the patient as well as a current medical and drug history were elicited. This data was compared with data attained during initial patient interaction with the service.
Early weight loss, defined as weight lost in the 4 weeks following surgery, was subsequently correlated with outcomes in terms of weight loss and improvement/resolution of either hypertension or diabetes at a 7 year follow up interval.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic sleeve gastrectomy
Form of obesity surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have not undergone any further bariatric surgical procedures since the index operation
* Still be alive at the time of the study
* Have correct be contactable with the contact details present available in the electronic database
Exclusion Criteria
* Uncontactable
* Unwilling to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Tankel
Resident in General Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shaare Zedek Medical Center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SZMC-95/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.